QuanTx provides quantitative clinical pharmacology consulting services in drug development. Our services include population PK, PKPD, ER, MBMA modeling and simulation, strategic guidance from translational to post-marketing settings, and mentoring new scientists on drug development projects. We'd be delighted to hear from you! Visit our website and send us a message: https://www.quantxconsulting.com/Employment: We're looking for colleagues with interest in hands-on work in QCP consulting. We collaborate from remote working environments. Please contact Russ Wada (russ.wada@quantxc.com)Examples of Work:Population Pharmacokinetics of Trastuzumab Deruxtecan in Patients With HER2-Positive Breast Cancer and Other Solid Tumors (https://pubmed.ncbi.nlm.nih.gov/33118153/)Selinexor population pharmacokinetic and exposure-response analyses to support dose optimization in patients with diffuse large B-cell lymphoma (https://pubmed.ncbi.nlm.nih.gov/33770229/)Exposure-Response Relationships in Patients With HER2-Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan (https://pubmed.ncbi.nlm.nih.gov/33999422/)